Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Complications of Ibrutinib Therapy: a Single-center Cohort Study

NCT05939752 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Dijon as lead sponsor.

NCT NCT05939752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Complications of Ibrutinib Therapy: a Single-center Cohort Study
Lead sponsor
Centre Hospitalier Universitaire Dijon
Phase
Observational
Overall status
Terminated
Start date
December 20, 2023
Completion date
August 5, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibrutinib treatment